c19early.com [1] lists numerous studies for Ivermectin and other drugs in the use of treating COVID-19 for both early treatment, and throughout all stages.
Ivermectin currently sits at an average efficacy of 65% after 81 studies.
So in reality, this study that WSJ cites should be added to the pool of efficacy, and not used to completely debunk Ivermectin.